Epidemiological Alert, Final Statement by PAHO/WHO on Investigation of Serious Adverse Events following Receipt of Yellow Fever Vaccine Produced by Bio-Manguinhos, Brazil (27 March 2008)
Alerta Epidemiológica, Comunicación final de la OPS/OMS sobre investigación de eventos adversos graves en Perú posteriores a la vacunación con vacuna antiamarílica elaborada por Bio-Manguinhos, Brasil (27 marzo 2008)
MetadataShow full item record
Showing items related by title, author, creator and subject.
Regional Risk Assessment on Vaccine−Preventable Diseases (Diphteria, Measles, Yellow Fever, and Polio) in the Context of the COVID−19 Pandemic: Implications for the Region of the Americas (15 December 2021) Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2021-12-15)After more than 22 months of the ongoing COVID-19 pandemic in the Region of the Americas, and COVID-19 cases and deaths have been reported from all 56 countries and territories in the Region of the Americas, health systems ...
Porudominsky, Ruben; Gotuzzo, Eduardo H. (2018-05)[ABSTRACT]. Objective. To evaluate contraindications and precautions for the yellow fever vaccine (YFV) in risk populations. Methods. A literature review was conducted by searching PubMed for “yellow fever vaccine” and ...
Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., OPS, 2021-10-14)In 2021, three countries in the Region of the Americas (Brazil, Peru, and Venezuela) have reported confirmed yellow fever cases. In 2020, two countries in the Region of the Americas reported confirmed cases of yellow fever: ...